Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GLP-1 weight-loss drugs might help protect kidneys
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes.
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.
Study Finds GLP-1 Meds Can Also Help the Kidneys
GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity Folks taking the meds have significantly lower odds for kidney failure The drugs also appear to have big heart health benefits TUESDAY,
Popular diabetes and obesity drugs also protect kidneys, study suggests
Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.
6h
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
16h
on MSN
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
21m
Biden wants to expand access to Ozempic and other popular weight loss drugs
The Biden-Harris administration proposed a new rule on Tuesday that would expand coverage of the anti-obesity medications ...
3m
How to Navigate the Holidays on a Weight-Loss Drug
For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...
6h
on MSN
Biden wants Medicare, Medicaid to cover pricey weight-loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...
2h
on MSN
Amgen shows 20% weight loss in once-monthly injectable MariTide
Amgen's (AMGN) once-monthly GLP-1, which experts expect to be a game changer in the weight-loss space, is showing continued ...
1h
on MSN
These Are the Thanksgiving Foods You Should Skip if You’re on Ozempic or Other Weight Loss Drugs
If you’re taking a GLP-1 medication, some foods should be avoided — including a traditional favorite Getty There are a few ...
14h
More Ozempic Users Doubt They Can Keep Weight Off Without Drug: Study
Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...
KTEN
16h
Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
The Biden administration is set to propose legislation allowing Medicare and Medicaid to cover the cost of
GLP-1
obesity ...
3h
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Food and Drug Administration
United States
Glucagon-like peptide-1
Amgen
MariTide
Feedback